Bibliography
- JOSE P, GRIFFITHS-JOHNSON DA,COLLINS PD et al.: Eotaxin, a potent eosinophil chemoattractant cytokine detected in guinea pig model of allergic airways inflammation ./. Exp. Med. (1995) 179:881–887.
- PONATH PD, QIN S, RINGLER DJ et al: Cloning of the human eosinophil chemoattractant, eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. j. Gun. Invest. (1996) 97:3604–3612.
- KITAURA M, SUZUKI N, IMAI T et al: Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. j. Biol. Chem. (1999) 274(39):27975–27980.
- TERAN LM: CCL chemokines and asthma. Immunol Today(2000) 5:235–242.
- CONROY DM, WILLIAMS TJ:Eotaxin and the attraction of eosinophils to the asthmatic lung. Respir. Res. (2001) 2:150–156.
- PEASE JE, WILLIAMS TJ: Eotaxin and asthma. Carr. Opin. Pharmacol (2001) 1(3):248–253.
- BERTRAND CP, PONATH PD: CCR3 blockade as a new therapy for asthma. Expert Opin. Investig. Drugs (2000) 9(1):43–52.
- WHITE JR, LEE JM, DEDE K et al: Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration. Biol. Chem. (2000) 275(47):36626–36631.
- DHANAK D, CHRISTMANN LT, DARCYMG et al: Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2 Bioorg. Med. Chem. Lett (2001) 11(11):1445–1450
- HARRIS R, MCKEEGAN E, MAJEST S et al: The discovery of new selective antagonists of CCR3. Inflamm. Res. (2000) 49 (Suppl. :S 10 1.
- NAYA A, KOBAYASHI K, ISHIKAWA M et al: Discovery of a novel CCR3 selective antagonist. Bioorg Med. Chem. Lett. (2001) 11(9):1219–1223.
- WACKER DA, SANTELLA JB GARDNER DS et al.: CCR3 antagonists: a potential new therapy for the treatment of asthma. Discovery and structure-activity relationships. Bioorg. Med. Chem. Lett. (2002) 12(13):1785–1789.
- DE LUCCA GV, KIM UT, JOHNSON C et al.: Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists../. Med. Chem. (2002) 45:3794–3804.
- SODERBERG C, GATER PR, BHAKTA S et al.: Characterization of CCR3 receptor antagonists using ligand binding and functional assays. Am. .1 Respir. Grit. Care Med. (2002):165:A41.
- BRYAN SA, JOSE PJ, TOPPING JR et al.:Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists. Respir. Crit. Care Med (2002) 165:1602–1609.
- MENZIES-GOW A, ROBINSON DS: Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma. Carr. Opin. Palm. Med. (2002) 8:33–38.
- LECKIE MJ, TEN BRINKE A, KHAN J et al.: Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. (2000) 356:2144–2148